Terms: = Thyroid cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Staging
45 results:
1. Dosimetry during iodine-131 therapy - a technical point of view from a single centre's own experience.
Chalewska W; Cegla P; Moczulska A; Strzemecka E; Sackiewicz A; Dedecjus M
Nucl Med Rev Cent East Eur; 2024; 27(0):1-5. PubMed ID: 38529769
[TBL] [Abstract] [Full Text] [Related]
2. The value of the first postoperative diagnostic I-131 scan in patients with papillary thyroid carcinoma.
Ran B; Shang J; Chen Y; Zhou M; Li H; He W; Li Y; Cai Q; Guo B; Gong J; Xu H
J Cancer Res Clin Oncol; 2024 Feb; 150(2):80. PubMed ID: 38319395
[TBL] [Abstract] [Full Text] [Related]
3. Impact of microscopic extrathyroidal extension on differentiated thyroid cancer post-surgical risk of recurrence: a retrospective analysis.
Patti L; Gay S; Musso L; Maltese C; Spina B; Minuto M; Morbelli S; Vera L; Boschetti M; Ferone D; Albertelli M
J Endocrinol Invest; 2023 Oct; 46(10):2157-2164. PubMed ID: 36976482
[TBL] [Abstract] [Full Text] [Related]
4. [Risk factors for recurrence and survival analysis in locally advanced T4a papillary thyroid carcinoma after R0 resection].
Chen JM; Fang JG; Zhong YS; Lin LZ; Hou HZ; Ma L; Feng SZ; He Q; Shi M; Lian R; Wang XX; Shen X
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Sep; 57(9):1044-1051. PubMed ID: 36177557
[No Abstract] [Full Text] [Related]
5. Histopathological Characteristics of N1b Papillary thyroid Carcinoma are Associated with Risk of Recurrence.
Carmel Neiderman NN; Duek I; Kuzmenko B; Ringel B; Warshavsky A; Muhanna N; Horowitz G; Fliss DM
World J Surg; 2022 Aug; 46(8):1917-1925. PubMed ID: 35543736
[TBL] [Abstract] [Full Text] [Related]
6. Evaluation of Diagnostic Value of SPECT/CT Imaging in Post-radioiodine Therapy in thyroid cancer.
Al Hatmi A; Jain A; Mittal AK; Hussain S
Sultan Qaboos Univ Med J; 2022 Feb; 22(1):74-81. PubMed ID: 35299812
[TBL] [Abstract] [Full Text] [Related]
7. Reduction of overtreatment without reduction of overdiagnosis in patients with differentiated thyroid cancer: mission impossible.
Oblak T; Perhavec A; Hocevar M; Peric B
Langenbecks Arch Surg; 2021 Sep; 406(6):2011-2017. PubMed ID: 34097134
[TBL] [Abstract] [Full Text] [Related]
8. The impact of radioactive iodine treatment on survival among papillary thyroid cancer patients according to the 7th and 8th editions of the AJCC/TNM staging system: a SEER-based study.
Liu X; Fan Y; Liu Y; He X; Zheng X; Tan J; Jia Q; Meng Z
Updates Surg; 2020 Sep; 72(3):871-884. PubMed ID: 32342347
[TBL] [Abstract] [Full Text] [Related]
9. Efficacy of low radioiodine activity versus intermediate-high activity in the ablation of low-risk differentiated thyroid cancer.
Albano D; Bonacina M; Durmo R; Bertagna F; Giubbini R
Endocrine; 2020 Apr; 68(1):124-131. PubMed ID: 31784881
[TBL] [Abstract] [Full Text] [Related]
10. Prognostic Significance of Cyclin D1 Over-expression in Colorectal cancer: An Experience from Madinah, Saudi Arabia.
Albasri AM; Elkablawy MA; Ansari IA; Alhujaily AS
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2471-2476. PubMed ID: 31450922
[TBL] [Abstract] [Full Text] [Related]
11. Association Between Programmed Death-Ligand 1 Expression and Clinicopathological Characteristics, Structural Recurrence, and Biochemical Recurrence/Persistent Disease in Medullary thyroid Carcinoma.
Shi X; Yu PC; Lei BW; Li CW; Zhang Y; Tan LC; Shi RL; Wang J; Ma B; Xu WB; Wang X; Hu JQ; Huang NS; Wei WJ; Wang Y; Chen TZ; Wang YL; Ji QH
Thyroid; 2019 Sep; 29(9):1269-1278. PubMed ID: 31328653
[No Abstract] [Full Text] [Related]
12. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
[TBL] [Abstract] [Full Text] [Related]
13. Usefulness of iodine-123 whole-body scan in planning iodine-131 treatment of the differentiated thyroid carcinoma in children and adolescence.
Villani MF; Grossi A; Cassano B; Pizzoferro M; Ubertini G; Longo M; Garganese MC
Nucl Med Commun; 2018 Dec; 39(12):1121-1128. PubMed ID: 30260898
[TBL] [Abstract] [Full Text] [Related]
14. Central Lymph Node Status has Significant Prognostic Value in the Clinically Node-Negative Tall-Cell Variant of Papillary thyroid cancer Regardless of T-staging and Radioactive Iodine Administration: First Evidence From a Population-Based Study.
Shi X; Huang NS; Lei BW; Song KH; Shi RL; Wei WJ; Hu WP; Dong F; Wang Y; Wang YL; Ji QH
Ann Surg Oncol; 2018 Aug; 25(8):2316-2322. PubMed ID: 29845406
[TBL] [Abstract] [Full Text] [Related]
15. Temporal Trends in the Presentation, Treatment, and Outcome of Medullary thyroid Carcinoma: An Israeli Multicenter Study.
Hirsch D; Twito O; Levy S; Bachar G; Robenshtok E; Gross DJ; Mazeh H; Benbassat C; Grozinsky-Glasberg S
Thyroid; 2018 Mar; 28(3):369-376. PubMed ID: 29402183
[TBL] [Abstract] [Full Text] [Related]
16. [Clinical characteristics and prognosis of anaplastic thyroid carcinoma].
Wang JF; Zhu XH; Tan Z; Ge MH
Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):434-438. PubMed ID: 28635233
[No Abstract] [Full Text] [Related]
17. Variability of Serum Thyroglobulin Levels in Post- thyroidectomy Patients with Well-Differentiated thyroid cancer: the ATA Guidelines.
Silva F; Martin RJ; Figueroa J; Rincón F; Román D
P R Health Sci J; 2016 Sep; 35(3):142-6. PubMed ID: 27623139
[TBL] [Abstract] [Full Text] [Related]
18. Utility of Adding SPECT/CT Imaging to Post-Therapeutic Radioiodine Whole-Body Scan in Patients with Differentiated thyroid cancer.
Sriprapaporn J; Sethanandha C; Yingsa-nga T; Komoltri C; Thongpraparn T; Harnnanthawiwai C
J Med Assoc Thai; 2015 Jun; 98(6):596-605. PubMed ID: 26219165
[TBL] [Abstract] [Full Text] [Related]
19. Review of clinical and pathological features of 93 cases of well-differentiated thyroid carcinoma in pediatric age at the Lisbon Centre of the Portuguese Institute of Oncology between 1964 and 2006.
Silva-Vieira M; Santos R; Leite V; Limbert E
Int J Pediatr Otorhinolaryngol; 2015 Aug; 79(8):1324-9. PubMed ID: 26104479
[TBL] [Abstract] [Full Text] [Related]
20. Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary thyroid cancer.
Adam MA; Pura J; Goffredo P; Dinan MA; Reed SD; Scheri RP; Hyslop T; Roman SA; Sosa JA
J Clin Oncol; 2015 Jul; 33(21):2370-5. PubMed ID: 26077238
[TBL] [Abstract] [Full Text] [Related]
[Next]
